Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in Pediatric Pop.

The Reagan-Udall Foundation for the FDA, in cooperation with the Food and Drug Administration, convened a hybrid public meeting to gather input on the clinical use and safety concerns associated with orally ingestible unapproved prescription drug products containing fluoride for use in children. (0:00) Welcome (4:50) Opening Remarks (11:55) Session 1: Scope of Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in Clinical Practice (1:15:29) Session 2: Identifying Safety Concerns and Potential Risk Associated with the Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride

Original article online at: https://www.youtube.com/watch?v=qJVF_wrTsSk